testosterone undecanoate has been researched along with Dyslipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilowski, W; Krysiak, R; Okopien, B | 1 |
| Borisov, VV; Kalinchenko, SIu; Novikova, MS | 1 |
1 review(s) available for testosterone undecanoate and Dyslipidemia
| Article | Year |
|---|---|
[Metabolic syndrome and chronic disease of the kidneys: the role of age-related androgenic deficiency. New approaches to treatment (review)].
Topics: Age Factors; Androgens; Dyslipidemias; Humans; Hypertension; Hypolipidemic Agents; Insulin Resistance; Kidney Failure, Chronic; Lactones; Metabolic Syndrome; Orlistat; Progesterone-Binding Globulin; Testosterone; Tumor Necrosis Factor-alpha; Tunica Intima | 2008 |
1 other study(ies) available for testosterone undecanoate and Dyslipidemia
| Article | Year |
|---|---|
The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late-Onset Hypogonadism and Atherogenic Dyslipidemia.
Topics: Aged; Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol, HDL; Dyslipidemias; Fenofibrate; Humans; Hypogonadism; Hypolipidemic Agents; Lipids; Male; Middle Aged; Prospective Studies; Risk Factors; Testosterone | 2015 |